BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28412208)

  • 41. Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer.
    Hu L; Chen HY; Cai J; Zhang Y; Qi CY; Gong H; Zhai YX; Fu H; Yang GZ; Gao CF
    BMC Cancer; 2015 Apr; 15():246. PubMed ID: 25884558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
    BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The relationship of A Proliferation-Inducing Ligand expression with the clinical pathology and prognosis in colorectal carcinoma].
    Mei HJ; Wang H; Zheng XB; Jin Q; Wang Y; Huang F; Zhang S
    Zhonghua Yi Xue Za Zhi; 2016 Nov; 96(40):3232-3235. PubMed ID: 27852390
    [No Abstract]   [Full Text] [Related]  

  • 45. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer.
    Jeong D; Kim H; Ban S; Oh S; Ji S; Kim D; Ahn TS; Kim HJ; Bae SB; Kwon HY; Im J; Lee MS; Cho HD; Kim CJ; Baek MJ
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2493-2503. PubMed ID: 28875407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.
    Imaoka H; Toiyama Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Carcinogenesis; 2015 Mar; 36(3):346-54. PubMed ID: 25568185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
    Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
    Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
    Wu HK; Liu C; Fan XX; Wang H; Zhou L
    Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
    Xiong B; Cheng Y; Ma L; Zhang C
    Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Expression of NF-E1b in colorectal cancer tissues and its clinical significance].
    Xu K; Chen L; Di J; Wang Z; Wang A; Wu W; Wu F; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):685-9. PubMed ID: 27353105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High expression of ROR2 in cancer cell correlates with unfavorable prognosis in colorectal cancer.
    Mei H; Lian S; Zhang S; Wang W; Mao Q; Wang H
    Biochem Biophys Res Commun; 2014 Oct; 453(4):703-9. PubMed ID: 25301559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis.
    Wang CG; Ye YJ; Yuan J; Liu FF; Zhang H; Wang S
    World J Gastroenterol; 2010 May; 16(19):2421-7. PubMed ID: 20480530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.
    Giannuzzo A; Pedersen SF; Novak I
    Mol Cancer; 2015 Nov; 14():203. PubMed ID: 26607222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
    Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
    Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AF1q Mediates Tumor Progression in Colorectal Cancer by Regulating AKT Signaling.
    Hu J; Li G; Liu L; Wang Y; Li X; Gong J
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. P2X7R promotes angiogenesis and tumour-associated macrophage recruitment by regulating the NF-κB signalling pathway in colorectal cancer cells.
    Yang C; Shi S; Su Y; Tong JS; Li L
    J Cell Mol Med; 2020 Sep; 24(18):10830-10841. PubMed ID: 32735377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
    Liu C; Zhou S; Ke CS; Li NP; Wu RL
    Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer.
    Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
    PLoS One; 2015; 10(10):e0139727. PubMed ID: 26426996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.